We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ixico Plc | LSE:IXI | London | Ordinary Share | GB00BFXR4C20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.25 | -3.28% | 7.375 | 7.25 | 7.50 | 7.625 | 7.375 | 7.63 | 30,696 | 11:23:58 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
31/3/2021 20:52 | Hi all, My mate Peter @Conkers3 and myself did a ‘Twin Petes Investing’ Podcast last week and IXI was one of the Stocks we discussed as Peter C3 himself holds it and it delivered up an unpleasant surprise. He talks about his strategy for what he intends to do next with IXI etc. Also in this episode we have a Special Guest Star in the form of Tim Rogers, who was the former CEO at ABDP. He gives loads of insights into the likely future for the Car Market and also gives some background etc. around ABDP. As always we also chatted about loads of other Stocks and Ideas for research and a fair bit of educational stuff with regards to Investing and Portfolio Management. Sadly we didn’t get time to chat about Tim’s classic motorcycle collection !! Anyway, if you use Youtube, Apple, Audioboom, Overcast, Google+ or Spotify you can find it under the 'Conkers Corner' Channel (you want Podcast TPI 45) and you can find it on Soundcloud at the link below. I hope you enjoy it and find it useful, we try to keep them light and they are totally unscripted, with the intent being that it is like you are eavesdropping on us having a chat down the local boozer (we can dream !!). Cheers, WD @wheeliedealer | thewheeliedealer | |
31/3/2021 14:51 | HodHar....What an Idiot you are!! Now DCB in play and further falls due. IXI can fall very quickly. 50p or less as No News is Bad News....Risky at these levels...be aware.. | halfpenny | |
31/3/2021 13:47 | If you can read an RNS, you know that this recent announcement, even in a worst case scenario has little to no impact longer term. Right business, in a hot area, at the right time. | hodhasharon | |
31/3/2021 12:56 | IXI a further fall is likely as the facts are released. No crumbs left on the cancelled deal so now very risky at this level. Lets see who is right 50p otr less soon. DCB in play!!! No news is Bad News!! | halfpenny | |
31/3/2021 11:24 | complete nonsense. halfpenny, or halfwhit? | hodhasharon | |
31/3/2021 11:01 | IXI be aware this could be a Dead Cat Bounce. Chart shows further falls below 50p. News flow not looking good short term!! | halfpenny | |
30/3/2021 12:05 | Prediction: 80p - 75p - 120p+ (at a very minimum). For EW followers. We're at the base of W4 (Outcome:Break the W3 top next). OR We've just completed WC of 2 (Outcome: W1 of 3 to come next) DYOR | hodhasharon | |
29/3/2021 20:45 | If you say so. I will do that first thing tomorrow. | bmel | |
29/3/2021 16:34 | Rubbish disaster companySell | r1singson | |
25/3/2021 08:21 | No credibility whatsoever here until management provide "committed order book" as well as "contracted order book", the latter as we recently learnt being complete BS. Contrast that with say SPSY which has a $50m order not reflected in broker forecasts simply because they are not sure which years the revenue will fall into. | shanklin | |
24/3/2021 20:52 | IXI will survive - they have plenty of cash on the balance sheet. Its not a solvency issue - they just need to right-size the cost base to be appropriate for the level of business which they have. I'd therefore expect a lot of job losses and restructuring costs, and the business to be meaningfully smaller in 6 months' time. Given that its guesswork what that business looks like, for me its uninvestable at present - just not my style. For those who like turnarounds, maybe they'd look at it, but its a different investment proposition and equity story to the growth focus from before, so I'd expect some churn in the shareholder base. Never nice to see these situations, and even less nice to own shares in these companies as I did! | adamb1978 | |
24/3/2021 20:13 | More news anyone ? | halfpenny | |
24/3/2021 10:40 | The March contract news has impacted sentiment but the long-term growth potential remains, comments Investor's Champion. | energeticbacker | |
24/3/2021 09:48 | Yep, the bargain hunters are out .. I've put a limit buy at 48p it may never get there, but I'm not so sure I want to pay more | red ninja | |
24/3/2021 09:46 | More news ? | halfpenny | |
24/3/2021 09:43 | Can sell 30k but cannot buy 10k atm, | firw00d | |
24/3/2021 09:34 | Price still drifting downward now offer price at 56.8p. This still appears to be a falling knife. | red ninja | |
24/3/2021 00:57 | PYC seem to have clients with successful clinical trials. Especially to date Bicycle BCYC Merck MRK.DE | thiopia | |
23/3/2021 21:52 | IXI is a quality company but this is going to sting for a while but cancellations are part and parcel of the business when you work in trials. One aspect to keep in mind is when you see a large trial fail you will often see the industry pause new work in that area for a while. You can look at the experience of Cogstate in Australia and COG after a series of high profile AD trials and the initial Aducanumab futility results it took 18 months for that market to properly get back to business. Also these cancellations can cluster if they have other clients working on the same MOA as Huntingdon has been a big focus for IXI. | 40 fathoms | |
23/3/2021 20:03 | IXI bounce back will be a great opportunity | halfpenny | |
23/3/2021 17:10 | Try ITX for research purposes. Imho | jpuff | |
23/3/2021 16:37 | I got luckyish too having sold a third in the last couple of days on the immaterial cloud news. Remainder out at 86.5 and 79.95, of which the former I was pretty happy with given it had traded there recently. Can't complain at the profits overall even if a fair chunk given back right at the end. | hpcg | |
23/3/2021 16:25 | I got lucky, as I only had a handful left as I had decided to sell into strength - a previous poster having flagged the high dependency on the one customer which I wasn't aware of - and that MS collaboration RNS provided (which, by the way, I thought was pretty immaterial) the strength. Not sure you could have avoided it unless you had specific industry (company?) knowledge, and if we only invest in stuff we have detailed knowledge of, then there ain't much time for anything else. No recommendations I'm afraid, I tend to stick to stable strong balance sheet dividend payers, and dabble a bit in everything else. Recent additions include SCS (modest position) and Norcross (looks more interesting, hoping to add on any weakness) to capture excess funds in UK household (and SA in the case of Norcross) bank accounts which have nothing else to be spent on. Not much IP there! | frazboy | |
23/3/2021 15:58 | Thanks Frazboy. Yes, the customer concentration was flagged, and was a reason why I thankfully hadn't added further my position. I'll watch from the sidelines now and see where the price and next set of results settle down. Always useful in these situations to think through whether I should have been able to see this coming. Will do that over the coming days. Its also worth remembering not to beat yourself up too much either. Investing in a probabilistic game - some you win, some you lose, and you cant know the future in advance. You just need to get more right than wrong, and you WILL get some wrong. On to the next one - any suggestions for IP-rich, high ROCE small/mid caps?!? | adamb1978 | |
23/3/2021 15:52 | IXI still has great prospect with MSoft deal. Now they can focus on new development. The main contract will still partly continue as IXI products are still essential. Opportunity to top up and make a handsome gain from the current bottom. Keep on as it now means they will not be locked onto a main customer. Future looking bright. Great Product, Price and Position in this multi billion pound market with great potential. | halfpenny |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions